Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7RUN

Crystal structure of phosphorylated RET tyrosine kinase domain complexed with a pyrrolo[2,3-d]pyrimidine inhibitor.

Summary for 7RUN
Entry DOI10.2210/pdb7run/pdb
DescriptorProto-oncogene tyrosine-protein kinase receptor Ret, CHLORIDE ION, 1-(4-{(1s,3s)-3-[4-amino-5-(3-amino-4-chlorophenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl]cyclobutyl}piperazin-1-yl)ethan-1-one (3 entities in total)
Functional Keywordstyrosine-protein kinase, inhibitor, cell adhesion, transferase-transferase inhibitor complex, transferase/transferase inhibitor
Biological sourceHomo sapiens (Human)
Total number of polymer chains2
Total formula weight78276.55
Authors
Lee, C.C.,Spraggon, G. (deposition date: 2021-08-17, release date: 2022-01-19, Last modification date: 2023-11-15)
Primary citationMathison, C.J.N.,Yang, Y.,Nelson, J.,Huang, Z.,Jiang, J.,Chianelli, D.,Rucker, P.V.,Roland, J.,Xie, Y.F.,Epple, R.,Bursulaya, B.,Lee, C.,Gao, M.Y.,Shaffer, J.,Briones, S.,Sarkisova, Y.,Galkin, A.,Li, L.,Li, N.,Li, C.,Hua, S.,Kasibhatla, S.,Kinyamu-Akunda, J.,Kikkawa, R.,Molteni, V.,Tellew, J.E.
Antitarget Selectivity and Tolerability of Novel Pyrrolo[2,3- d ]pyrimidine RET Inhibitors.
Acs Med.Chem.Lett., 12:1912-1919, 2021
Cited by
PubMed: 34917254
DOI: 10.1021/acsmedchemlett.1c00450
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.51 Å)
Structure validation

218853

PDB entries from 2024-04-24

PDB statisticsPDBj update infoContact PDBjnumon